Statins Decrease the Risk of Orbitopathy in Newly Diagnosed Patients with Graves' disease. Nilsson A, Tsoumani K, Planck T. J Clin Endocrinol Metab 2021 Feb 9. pii: 6131732. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nilsson A, Tsoumani K, Planck T. Statins Decrease the Risk of Orbitopathy in Newly Diagnosed Patients with Graves' disease. J Clin Endocrinol Metab 2021 Feb 9. pii: 6131732. doi: 10.1210.
PMID: 33560351